BIOTECH NEWS
BESs
Merck Announces FDA Acceptance of New Drug Application for an Investigational Extended-Release Formulation of JANUMET® (sitagliptin/metformin HCI) for Type 2 Diabetes
| Posted on January 11, 2011 at 10:04 AM |
comments (0)
|
Watson to Host Investor Day on January 21 in New York City
| Posted on January 11, 2011 at 9:51 AM |
comments (0)
|
Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
| Posted on January 11, 2011 at 9:38 AM |
comments (0)
|
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 29th Annual J.P. Morgan Healthcare Conference on Thur...
XOMA Presents XOMA 3AB Data at National Biodefense Meeting
| Posted on January 11, 2011 at 9:20 AM |
comments (0)
|
XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced several presentations that highlight advances in the company's biodefense program and particularly in the development of XOMA 3AB, a three antibody formulation that binds to distinct regions of botulinum toxin type A. A...
Alnylam to Webcast Presentation at 2010 Deutsche Bank BioFEST
| Posted on December 9, 2010 at 10:13 AM |
comments (0)
|
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2010 Deutsche Bank BioFEST on Wednesday, December 15, 2010 at 1:05 p.m. ET at the Four Seasons Hotel Bos...
Cytokinetics to Host Investor Event on December 13, 2010
| Posted on December 9, 2010 at 10:06 AM |
comments (0)
|
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that the company is scheduled to host an Investor Event entitled "Perspectives on the Phase IIa Clinical Trial Data of CK-2017357 in Pa...
Acorda Therapeutics Announces Initiation of Phase 1 GGF2 Clinical Trial in Patients with Heart Failure
| Posted on December 9, 2010 at 10:00 AM |
comments (0)
|
Acorda Therapeutics, Inc.
BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
| Posted on December 7, 2010 at 10:55 AM |
comments (0)
|
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Joshua Grass, Vice President of Corporate and Business Development of BioMarin, will present a company update at the Deutsche Bank 2010 BioFEST Conference in
View Older Posts »
Blog
